Compare Medline Inc. Class A Common Stock (MDLN) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medline Inc. Class A Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Medline Inc. Class A Common Stock is the larger of the two by market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| MDLN | ROIV | |
|---|---|---|
Market Cap | $31.10B | $25.09B |
Volume | 4,471,639 | 5,738,571 |
Sector | Health | Health |
52-Week High | $49.99 | $41.81 |
52-Week Low | $31.64 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $41.07B | $21.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medline Inc. Class A Common Stock
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
